本文/A8133S
|
|
- やすもり みねむら
- 4 years ago
- Views:
Transcription
1 IL- IL- Mucosal immunology and IL- -induced intestinal injury Rei Kawashima School of Allied Health Sciences, Kitasato University, Kitasato, Minami-ku, Sagamihara, Kanagawa, Japan Toll-like receptor TLR TLR TLR T B T CD CD T CD CD T CD T IL- IL- IgA IgA IgA CD T pp.
2 T B IgA DC M CD T CD T CD T CD T B B Th -IL- CD T Th helper T IL- IL-IL- IL- R common IL- R IL- IL- R IL- IL- IL- R IL- R IL- IL- IL- R IL- R IL- IL- NK IL- IL- -catenin IL- Stat IL- IL- in vitro HT IL- IL- IL- R IL- R IL- R IL- IL- IL- STAT chitinase -like IL- R IL- R IL-
3 IL- R IL- IL- -catenin E-cadherin ZO- IL- HaKaT IL- ZO- IL- cell turnover IL- IL- TWEAK TWEAK tumor necrosis factor TNF Fn IL- NF- B TWEAK TNF TNF-like weak inducer TWEAK-Fn TWEAK TNBS TWEAK Fn TWEAK-Fn IL- TWEAK IL- TWEAK-Fn Fn IL- IL- -catenin Fn ZO- Fn IL- ZO- IL- IL- TACE ADAM TNF shedding IL- TWEAK Fn IL- TWEAK Fn IL-TWEAK FnTNF IL- TWEAK Fn TNF IL- TWEAK Fn IL- TWEAK-Fn IL- Th Th Th
4 IL- TWEAK Fn TNF shedding IL- TWEAK Fn TNF shedding TNF TNF TNF IL- TWEAK Fn IL- TWEAK FnTNF IL- TWEAK Fn IL- Zhu, Z., Lee, C.G., Zheng, T., Chupp, G., Wang, J., Homer, R. J., Noble, P.W., Hamid, Q., Elias, J.A. Am. J. Respir. Crit. Care Med.,, SS. Zurawski, S.M., Vega, F. Jr., Huyghe, B., Zurawski, G. EMBO J.,,. Kawashima, R., Kawamura, Y.I., Kato, R., Mizutani, N., Toyama-Sorimachi, N., Dohi, T.Gastroenterology,,. Rosen, M.J., Chaturvedi, R., Washington, M.K., Kuhnhein, L. A., Moore, P.D., Coggeshall, S.S., McDonough, E.M., Weitkamp, J.H., Singh, A.B., Coburn, L.A., Williams, C.S., Yan, F., Van Kaer, L., Peebles, R.S. Jr., Wilson, K.T.J. Immunol.,,. Wright K., Kolios, G., Westwick, J., Ward, S.G.J. Biol. Chem.,,. Blease, K., Schuh, J.M., Jakubzick, C., Lukacs, N.W., Kunkel, S.L., Joshi, B.H., Puri, R.K., Kaplan, M.H., Hogaboam, C. M.Am. J. Pathol.,,. He, C.H., Lee, C.G., Dela Cruz, C.S., Lee, C.M., Zhou, Y., Ahangari, F., Ma, B., Herzog, E.L., Rosenberg, S.A., Li, Y., Nour, A.M., Parikh, C.R., Schmidt, I., Modis, Y., Cantley, L., Elias, J.A.Cell Rep.,,. Chen, W., Sivaprasad, U., Gibson, A.M., Ericksen, M.B., Cunningham, C.M., Bass, S.A., Kinker, K.G., Finkelman, F.D., Wills-Karp, M., Khurana Hershey, G.K.J. Allergy Clin. Immunol.,,. Fujii-Maeda, S., Kajiwara, K., Ikizawa, K., Shinazawa, M., Yu, B.,Koga,T.,Furue,M., Yanagihara, Y.J. Invest. Dermatol.,,. Kissoon-Singh, V., Moreau, F., Trusevych, E., Chadee, K. Am. J. Pathol.,,. Cliffe, L.J., Humphreys, N.E., Lane, T.E., Potten, C.S., Booth, C., Grencis, R.K.Science,,. Kawashima, R., Kawamura, Y.I., Oshio, T., Son, A., Yamazaki, M., Hagiwara, T., Okada, T., Inagaki-Ohara, K., Wu, P., Szak, S., Kawamura, Y.J., Konishi, F., Miyake, O., Yano,H.,Saito,Y.,Burkly,L.C., Dohi, T.Gastroenterology,,. Dohi, T., Borodovsky, A., Wu, P., Shearstone, J.R., Kawashima, R., Runkel, L., Rajman, L., Dong, X., Scott, M.L., Michaelson, J.S., Jakubowski, A., Burkly, L.C.Gastroenterology,,. Bailey, J.R., Bland, P.W., Tarlton, J.F., Peters, I., Moorghen, M., Sylvester, P.A., Probert, C.S., Whiting, C.V. PLoS ONE,, e. Son, A., Oshio, T., Kawamura, Y.I., Hagiwara, T., Yamazaki, M., Inagaki-Ohara, K., Okada, T., Wu, P., Iseki, M., Takaki, S., Burkly, L.C., Dohi, T.Mucosal Immunol.,,. Dohi, T. Burkly, L.C.J. Leukoc. Biol.,,.
5 CREST
CRA3689A
AVIC-DRZ90 AVIC-DRZ80 2 3 4 5 66 7 88 9 10 10 10 11 12 13 14 15 1 1 0 OPEN ANGLE REMOTE WIDE SET UP AVIC-DRZ90 SOURCE OFF AV CONTROL MIC 2 16 17 1 2 0 0 1 AVIC-DRZ90 2 3 4 OPEN ANGLE REMOTE SOURCE OFF
More information2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1
Mg-LPSO 2566 2016 3 2001 Mg-Zn-Y LPSO(Long Period Stacking Order) Mg,,,. LPSO ( ), Mg, Zn,Y. Mg Zn, Y fcc( ) L1 2. LPSO Mg,., Mg L1 2, Zn,Y,, Y.,, Zn, Y Mg. Zn,Y., 926, 1 1,.,,., 1 C 8, 2 A 9.., Zn,Y,.
More information19 8 1970 20 10 4 1
19 8 1970 20 10 4 1 IgE 1960 % 1970 20%, 1990 40% 1998 70% 20 IgE 21 90% IgE IgE (%) 70 60 50 40 30 20 10 0 1970 1975 1980 1985 1990 1995 2000 2005 1. 2005 10 2 30 IgE 2. 3 1. B IgE T IgE IgE IgE 2 T IgE
More information36 th IChO : - 3 ( ) , G O O D L U C K final 1
36 th ICh - - 5 - - : - 3 ( ) - 169 - -, - - - - - - - G D L U C K final 1 1 1.01 2 e 4.00 3 Li 6.94 4 Be 9.01 5 B 10.81 6 C 12.01 7 N 14.01 8 16.00 9 F 19.00 10 Ne 20.18 11 Na 22.99 12 Mg 24.31 Periodic
More information本文/AY380J
MHC-II II MHC-II MHC- II CD T T TCR T T MHC-II MHC-II T MHC-II MHC-II MHC-II MHC-II Ii Ii-MHC-II MHC-II antigen processing compartment MIIC Regulation of cell surface expression of MHC-II in dendritic
More information福岡大学人文論叢47-3
679 pp. 1 680 2 681 pp. 3 682 4 683 5 684 pp. 6 685 7 686 8 687 9 688 pp. b 10 689 11 690 12 691 13 692 pp. 14 693 15 694 a b 16 695 a b 17 696 a 18 697 B 19 698 A B B B A B B A A 20 699 pp. 21 700 pp.
More information23 3 11 14 46 9.0 7 10m 40.1m 15,883 2,681 25 4 10 39 40 800 180 24 2425 22 21 24 5 3 21 24 10,899 20,472 13,723 33,007 667 400 79,167 8,620 11,694 10,089 25,131 690 215 56,439 13,614 20,897 15,200 32,213
More informationÿþ
TNF ファミリー 腫瘍壊死因子 ( Tumor Necrosis Factor: TNF) は 固形がんに対して出血性の壊死を誘導する因子として発見されたサイトカインです TNF ファミリーには TNF-α リンフォトキシンα Fas リガンドや TRAIL などのアポトーシス誘導に関与するサイトカインのほか RANK リガンド OX40 リガンド APRIL など 20 種類近くに因子が同定されています
More information1 509 12kg 1 ( ) L 9/19 6 00 SA8 20---8 30 PA10 30 IC12 30 12 40 13 12 14 00 15 40 9/20 4 00--- 5 30--- 6 20 7 00-8 00---8 15 9 20 7 9 45---10 00 10 40--- 11 00 11 45---11 55 12 20---12 35 13 20 14 40
More information180 140 22
21 180 140 22 23 25 50 1 3 350 140 500cm 600 140 24 25 26 27 28 29 30 31 1/12 8.3 1/15 6.7 10 1/8 12.5 1/20 140 90 75 150 60 150 10 30 15 35 2,000 30 32 1 1 1 2 1 3 1 4 1 5 1 6 1 7 1 8 1 9 % 100 50 33.3
More information<82D282A982C1746F95F18D908F57967B95B E696E6464>
1 2 (90cm 70cm 2015) 3 (68cm 28cm 30cm 12kg 2015) (77.5 109.5cm 2015) 4 (22cm 50cm 50cm 4.6kg 2015) (45cm 62.5cm 2015) (47.4cm 62.5cm 2014) 5 (28.5cm 23.5cm) (45cm 62cm 2015) (97cm 107cm 2015) 6 7 8 9
More information6 12 10661 93100 227213202 222208197 85kg cm 20 64.521 106856142 2 1 4 3 9767 100 35 cm 7747 208198 90kg 23 5828 10661 93100 cm 227213202 10639 61 64.521 85kg 78kg 70kg 61 100 197204.5 cm 15 61
More information本文/YA9255C
pp. E- -SH X in vitro in vivo -SH Structure-based drug development and medical biological application of cathepsin specific inhibitors Nobuhiko Katunuma Institute for Health Sciences, Tokushima Bunri University,Nishihamabouji,
More information03J_sources.key
Radiation Detection & Measurement (1) (2) (3) (4)1 MeV ( ) 10 9 m 10 7 m 10 10 m < 10 18 m X 10 15 m 10 15 m ......... (isotope)...... (isotone)......... (isobar) 1 1 1 0 1 2 1 2 3 99.985% 0.015% ~0% E
More informationC TE-2500
C TE-2500 n n n n n n n n n n n n n n n n n m OP PGM r N j j L J j R j # j j y j F j f j - j m j P j p j t j j r j ø v Å j x j j u j 1 9 0^. n j j d j A j $! j $ $ j E e j o j i j c j k j j g j j
More information1) van Meer, G., Op den Kamp, J. A.: J. Cell. Biochem., 19, 193-2040982) 2) Gaffet, P., Bettache, N., Bienvenue, A.: Biochemistry, 34, 6762-6769(1995) 3) Sims, P. J., Wiedmer, T.: Thromb. Haemost., 86,
More information™…{,
16:30-17:40 1-36 1-37 1-38 1-39 1-40 1-41 1-42 33 10:00-11:10 1-43 1-44 1-45 1-46 1-47 1-48 1-49 12:00-12:50 LS4 34 16:30-17:40 1-50 1-51 1-52 1-53 1-54 1-55 1-56 35 16:30-17:40 1-57 1-58 1-59 1-60 1-61
More information音声読み上げブラウザの読み上げかた
IBM 3.01, 1,234 1 HTML 2 1+1 1+1= 1 1 1 1= 1 1 1 1= 1X1 3 2004 11 14 10 2004 11 14 2004-11-14 2004/11/14 11/14 10:00 10:00am am pm a.m.p.m. 4 10 5 1 1 1 10 1 100 10 1 10 10 113 10 1 5 6 23 5372 0859 23
More information07.報文_及川ら-二校目.indd
8 01 01 4 4 1 5 16 18 6 006 H 18 4 011 H 6 4 1 5 1 5 007 H 19 5 009 1 5 006 007 009 011 9 10 4 000 H 1 4 5 004 H 16 4 004 009 H 1 5 4 4 5 1 4 006 011 1 1 4m 5m 10m 007 1 7 009 009 1 5 10 1 000kg 10a 006
More information本文/YA4096E
Montiel, M.D., Krzewinski-Recchi, M.A., Delannoy, P., & Harduin-Lepers, A.Biochem. J.,,. Nagata, Y., Yamashiro, S., Yodoi, J., Lloyd, K.O., Shiku, H., & Furukawa, K.J. Biol. Chem.,,. Dohi, T., Nishikawa,
More information<90CE90EC88E290D55F955C8E862E656336>
5 5 9 9 7 7 5 5 6 6 7 7 8 8 9 9 8 8 8 8 79 79 78 78 76 76 77 77 7 7 6 7 7 5 68 68 67 67 66 66 65 65 6 6 6 6 6 6 6 6 6 6 59 59 58 58 57 57 56 56 55 55 5 5 8 8 5 5 9 9 9 8 7 9 9 8 8 7 7 6 6 5 5 5 5 69 69
More informationuntitled
5 28 EAR CCLECCN ECCN 1. 2. 3. 4. 5.EAR page 1 of 28 WWW.Agilent.co.jp -> Q&A ECCN 10020A 10070A 10070B 10070C 10071A 10071B 10072A 10073A 10073B 10073C 10074A 10074B 10074C 10076A 10229A 10240B 10430A
More information夏リニューアル第2弾記者発表20100611
2 MJ MAX GMA H.I.S. ONE PIECE in NE PIECE 2010 7 15 10 17 10 00 21 00 H.I.S. 500 400 H.I.S. ONE PIECE in POINT1 POINT2 OPEN POINT 200 100 2010 7 17 8 31 2010 6 19 8 31 400 300 7/17 8/31) 2010 7
More informationLipids of Seeds Manjiro NODA Department of Agricultural Chemistry, College of Agriculture, Kyoto Prefectural University (Sakyo-ku, Kyoto)
Lipids of Seeds Manjiro NODA Department of Agricultural Chemistry, College of Agriculture, Kyoto Prefectural University (Sakyo-ku, Kyoto) and Other Lipids", Vol. 11, p. 137 (1970) 2) C.Y. Hopkins,
More information第14〜15回 T細胞を介する免疫系.pptx
MBL CD8 CD4 8.1 8.2 5.20 8.3 8.4 8.5 8.6 8.7 8.8 8.9 8.10 8.18 B7 CD28 CD28 B7 CD28 8.13 2.22 NK Toll(TLR) LBP! LPS dsrna ssrna TLR1/2/6! TLR4 TLR5 TLR3 TLR7/9 CD14! JNK/p38! MyD88! IRAK! TRAF! NFκB! TNF-α
More information1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e
No. 1 1 1 H Li Be Na M g B A l C S i N P O S F He N Cl A e K Ca S c T i V C Mn Fe Co Ni Cu Zn Ga Ge As Se B K Rb S Y Z Nb Mo Tc Ru Rh Pd Ag Cd In Sn Sb T e I X e Cs Ba F Ra Hf Ta W Re Os I Rf Db Sg Bh
More information¹₄ ³₈ ³₈ ¹₂ ¹₂ ¹₂ ³₄ ³₄
33 4 5 2 63 2 1 3 1 4 2 5 6 19 ¹₄ ³₈ ³₈ ¹₂ ¹₂ ¹₂ ³₄ ³₄ 1 1 5 6 6 7 1 1 1 1 1 1 35 GDC LB 1 1 Y 2 A54 2 1 2 1 1 5 1 1 21 1 2 2 2 53 512 53 53 512 3 12 2 2 4 5 63 1 1 2 4 5 63 1 1 2 45 1 5 2 3 4 4 3 4 4
More informationCAR-T実施
Building a Clinical CAR-T Program - Jichi Medical University Experience l l l Anti-CD3/28 mabs & IL-2: 29% Anti-CD3/28 beads: 66% Retroviral: 41% Lentiviral: 54% T-Flasks: 22% Static Culture Bags: 35%
More informationEPSON LP-S7500シリーズ 取扱説明書1 セットアップと使い方編
A B K L N N N N A B A N B N N A B D A B A B N N N N N N N N N N N K A B E C D F G N N N A B N N A A K B C D L E L L K F A B G N C N N C D B K E A B F AC N K G A B C H K D F E B G H K I G H L J
More information福島県2012-初校.indd
2012 FUKUSHIMA http://www.kairyudo.co.jp/ 2 4 5 1 2 3 2 3 20092008 kg cm 1500m 1000m 20m 50 m cm m 12 25.08 6.15 24.66 6.17 22.03 4.23 22.08 4.45 13 30.32 6.40 30.10 6.99 24.37 4.17 23.97 4.48 14 35.10
More informationuntitled
1 1 12 15cm cm 30k 70k 2009 22,000t 2010 13,500t 1,871t 1,148t 2011,t ICCAT,t,t F F 300/400 10kg C/S 1000/1400g etc. etc etc. F kg 2/3 kg 1kg 11/15 etc etc.. etc. AM330 330 AM830 AM900 11 8 100
More information081116ヨコ/妹尾江里子 199号
Hardy et al. Paivio Martin et al. Cognitive Specific : CS Cognitive General : CG Motivational Specific : MSMotivational General Arousal : MG A Motivational General Mastery : MG M MS MG A MG M Hardy et
More informationJuntendo Medical Journal
The hair growth effect of minoxidil Susumu OTOMO, Ph. D. Key words : minoxidil, minoxidil sulfate, hair growth, K+-channel opener, male pattern baldness Dept. of Pharmacology, Research Center Taisho Pharmaceutical
More informationMajor Histocompatibility Complex 2018; 25 (2): 抄録集 2 HLA A 3 128
Major Histocompatibility Complex 2018; 25 (: 128 138 抄録集 2018 4 14 A 3 128 MHC 2018; 25 ( HLA 2013 10.5 10 8 12 10 8 2016 CD34 + HLA NC 10 8 CD34 + CD34 + 10 6 NC10.5 2013.Apr 2014.Mar NC11 2014.Apr 2016.Jun
More informationÿþ
インターロイキン インターロイキンは リンパ球や単球 マクロファージなどの免疫反応への寄与が知られる白血球から産生されることから 細胞間 ( inter-) 白血球 ( leukocyte -leukin) より Interleukin と名づけられました 現在までに 30 種類以上のインターロイキンが同定され 発見された順番に番号が付与されており 中にはケモカイン ( IL-8) やインターフェロン
More informationCytometry Research Kazuhiko Arima, MD, PhD, Hiroshi Shiraishi, PhD, and Kenji Izuhara, MD, PhD Division of Medical Biochemistry, Depar
Cytometry Research 25 1 13 18 2015 Kazuhiko Arima, MD, PhD, Hiroshi Shiraishi, PhD, and Kenji Izuhara, MD, PhD Division of Medical Biochemistry, Department of Biomolecular Sciences, Saga Medical School,
More information19 3 6 4 65 50 2 1 25.018.716.2 15.0 7 70.17.9 8 44.242.3 50.6 5 23.3 35.7 2 1 (SA) 2 (SA) 6 4 3 (SA) PTA 4 (SA) 7 50 5 (SA) 4 6 (3 ) 7 (SA) 8 2 1 8 3 30 50 9 (SA) 5 60 10 (SA) 2 11 (SA) 12 (MA) 40 13
More information本文/YAY143B
Suzuki, K., Kumanogoh, A., & Kikutani, H. Nat. Immunol.,,. Luo, Y., Raible, D., & Raper, J.A. Cell,,. Pasterkamp, R.J. & Kolodkin, A.L. Curr. Opin. Neurobiol.,,. Nogi,T.etal. Nature,,. Gu,C.etal. Science,,.
More informationミニレビュー
Molecular mechanisms of the suppression of inflammation by thermal stress Ryosuke Takii Department of Biochemistry and Molecular Biology, Yamaguchi University Graduate School of Medicine, Ube 755-8505,
More informationFORES II [フォレスII]
ORES Z7 M06 G699 MG59 M59 M49 M06 Z7 G699 1 JOIA ABS 02 231 1 2013-2014 40 -OPEN -LOK L L 1 1 L 735 A4BOX6 /653 2 601 A4BOX5 /525 257 40 2 OA 40 P252 1230 02 232 2 2013-2014 A B 9G-MP59 920RG-MP 59 106,6
More informatione ワラント満期決済金額一覧 (2016/3/9) EW_Code 種類 ワラントタイプ コード 対象原資産 回号 権利行使価格 1ワラント当り原資産数 適用為替 1ワラント当りの決済金額 参照原資産価格 J150056M eワラント コール 101 日経平均 , 円 0.0
J150056M eワラント コール 101 日経平均 884 17,500.00 円 0.002 1 0 円 16,625.59 円 J150063K eワラント コール 101 日経平均 891 19,500.00 円 0.002 1 0 円 16,625.59 円 J150069S eワラント コール 101 日経平均 897 21,000.00 円 0.002 1 0 円 16,625.59
More information無印良品 2012 自転車 カタログ
26 897895321,000 140cm 76.0cm 16.0kg H LED 3 263 897896025,000 140cm 76.0cm 16.5kg H 3 LED 20 8978984 8978977 19,800 134cm 73.0cm 15.0kg LED 2620 2620 8486656550 5536207483 14512372,100 8279999840 26 77342561,417
More informationレジャー産業と顧客満足の課題
1 1983 1983 2 3700 4800 5500 3300 15 3 100 1000 JR 4 14 2000 55% 72% 1878 2000 5 ( ) 22 1,040 5 946 42 15 25 30 30 4 14 39 1 24 8 6 390 33 800 34 34 3 35 () 37 40 1 50 40 46 47 2 55 4.43 4 16.98 40 55
More informationJournal of the Combustion Society of Japan Vol.58 No.185 (2016) ORIGINAL PAPER 火災旋風近傍の流れに関する研究 Flow Around a Fire Whirl *
58 185 2016 167-171 Journal of the Combustion Society of Japan Vol.58 No.185 (2016) 167-171 ORIGINAL PAPER 火災旋風近傍の流れに関する研究 Flow Around a Fire Whirl * ONISHI, Hiroyuki and KUWANA, Kazunori 992-8510 4-3-16
More information10 2 2 10 6.5 78 1 65 / 30 / - 2 -
- 1 - 10 2 2 10 6.5 78 1 65 / 30 / - 2 - 3 3 30 8 4 8 6 11 14 45 14 7 8 1-3 - 4 1 () 20 4 9 4 9 3 9 4 PR 4 3-4 - - 5 - PR 15 4 PR 7 8 4 9 10-6 - 9 10 9 10 4 9 10 3 9 10 9 9 9 10 PR 1-7 - PR - 8 - 30 100-9
More information14 D033 CR:16 15 E015 CR:18 16 E060 CR:15 17 D038 18 E059 19 E062 20 E063 21 E066 22 E064 23 E065 24 d031 25 E053 26 E048 27 E049 28 B009 29 D039 30 D
No QUEST CR 0 E051 1 E092 2 E093 3 E098 4 E099 5 D040 6 E100 7 E014 CR:14 ( 8 E010 9 E109 10 E045 11 E044 12 E028 13 E043 1 14 D033 CR:16 15 E015 CR:18 16 E060 CR:15 17 D038 18 E059 19 E062 20 E063 21
More informationVarious function and toxicity of iron Key words 1) Hentze, M. W. et al: Cell, 117, 285-297 (2004) 2) Ganz, T.: Blood, 102, 783-788 (2003) 3) Nemeth, E. et al.: Science, 306, 2090-2093 (2004) 4) Hentze,
More informationDatabase Center for Life Science Online Service Virus infection and interferon system
Virus infection and interferon system cing IFN-(3 ) /TICAM 1 (Toll-interleukin 1 receptor do main-containing adaptor molecule 1), TRAF6 (tumor necrosis factor receptor associated factor 6), TAB1 (TAK1-binding
More information(1) (2) (1) (2) (1) Seg (2) Seg (3) Seg (4) Seg (1) (2) (3) ( ) (1) (PCA)...12
(1)...109 (2)...110 (1) 28...111 (2) 28...113 (1) Seg...115 (2) Seg...117 (3) Seg...119 (4) Seg...120 (1)...122 (2)...122 (3) ( )...126 (1) (PCA)...127 (2) Draize...128 (1) Ames...129 2 in vitro...132
More information0 s T (s) /CR () v 2 /v v 2 v = T (jω) = + jωcr (2) = + (ωcr) 2 ω v R=Ω C=F (b) db db( ) v 2 20 log 0 [db] (3) v R v C v 2 (a) ω (b) : v o v o =
RC LC RC 5 2 RC 2 2. /sc sl ( ) s = jω j j ω [rad/s] : C L R sc sl R 2.2 T (s) ( T (s) = = /CR ) + scr s + /CR () 0 s T (s) /CR () v 2 /v v 2 v = T (jω) = + jωcr (2) = + (ωcr) 2 ω v R=Ω C=F (b) db db(
More informationŁ½’¬24flNfix+3mm-‡½‡¹724
571 0.0 31,583 2.0 139,335 8.9 310,727 19.7 1,576,352 100.0 820 0.1 160,247 10.2 38,5012.4 5,7830.4 9,5020.6 41,7592.7 77,8174.9 46,425 2.9 381,410 24.2 1,576,352 100.0 219,332 13.9 132,444 8.4 173,450
More informationuntitled
47 48 10 49 2005.6.1 17 500 50 1988 1994.1.1 16 22 51 18 1989 2005 17 2006 18 4 12 18 2007 19 1 12 2007 19 H18.8. J.H. 20 19 52 53 42.9 54 50 50 3080 55 30 100 56 57 22 96 6.8 9.4 31.44 58 10 780 250 59
More information経済論集 46‐1(よこ)(P)/2.三崎
1 1 14 2 1866 8 20 20 2 4 1871 20 3 4 2 1969 9 12 28 33 3 1970 35 5 1965 p.119. 1995 p.67 1960 p.86. 1965 p.120. 1927 p.5. 1942 p.127, p.129. 10 1877 7 12 16 6 10 7 10 1877 8 7 6 8 16 25 29 10 1877 9 1
More information橡紙目次第1章1
1 1 1 AstA A st t Q + = 0 Ast A st t y = bst ( y) t (1.1) (1.) y 1 Q + = 0 t b st q (1.3) (1.3) b st y Q + = q t (1.4) Abbott(1979) Q Q y + ( β ) + ga + gas f = 0 t A q u (1.5) Q Q y + ( β ) + ga + Sf
More informationPL Prof. Jean Gruenberg Department of Biochemistry, University of Geneva A L1 L A 18
PL L1L2 Y1Y5 S1S4 SS1SS8 LS PL Prof. Jean Gruenberg Department of Biochemistry, University of Geneva 8 30 15001600 A L1 L2 8 30 14001500 A 18 19 8 31 13001400 A Y1 Hirata A and Nakamura H. Localization
More information案内最終.indd
1 2 3 4 5 6 IC IC R22 IC IC http://www.gifu-u.ac.jp/view.rbz?cd=393 JR JR JR JR JR 7 / JR IC km IC km IC IC km 8 F HPhttp://www.made.gifu-u.ac.jp/~vlbi/index.html 9 Q01a N01a X01a K01a S01a T01a Q02a N02a
More informationSuper perfect numbers and Mersenne perefect numbers /2/22 1 m, , 31 8 P = , P =
Super perfect numbers and Mersenne perefect numbers 3 2019/2/22 1 m, 2 2 5 3 5 4 18 5 20 6 25 7, 31 8 P = 5 35 9, 38 10 P = 5 39 1 1 m, 1: m = 28 m = 28 m = 10 height48 2 4 3 A 40 2 3 5 A 2002 2 7 11 13
More information[15] 1970 Chiu [16, 17] [18-22] [20] Chiu [23] [24] [25] Chiu [16, 17] Chiu G 2
Spray Combustion. Droplet Group Combustion 1. ml 20 µm 2.4 [1-12] [13] [14] 1 [15] 1970 Chiu [16, 17] [18-22] [20] Chiu [23] [24] 2. 2-1. [25] Chiu [16, 17] Chiu G 2 N: TOTAL NUMBER OF DROPLETS 9 8 7 6
More information本文/YA9121A
pp. CD CDHA HA CD HABD NMR HABD C HA ordered O -state HA partially disordered PD -state PD-state CD HA HA CD CD A Two-state equilibrium of hyaluronan-binding domain is crucial for CD -mediated cell rolling
More information総合カタログ_P _深溝玉軸受
SKF@ptitudeCARBDynaSpinICOSINSO- COATLubriLeanMARLINMicrologNoWear SensorMountSYSTEM24VOGELWaveseal SKF SKF Group 2007 Catalogue 6000 JAOctober 2007 Catalogue 5000 E Printed in Japan 3,500+ ... 289...
More information日本皮膚科学会雑誌第121巻第14号
World J Surg Burns Burns JTrauma Lancet Lancet Surg Gynecol Obste J Burn Care Rehabil BMJ Pediatr Emerg Care The Treatment of Burns Burns, A Team Approach Surg Gynecol Obstet NEnglJMed J Burn Care Rehabil
More informationSyntheses of Medium-sized Ring Amines from Bicyclic Amines Yoshio ARATA* and Miyoji HANAOKA** Conversion of bicyclic amines into medium-sized ring ami
Syntheses of Medium-sized Ring Amines from Bicyclic Amines Yoshio ARATA* and Miyoji HANAOKA** Conversion of bicyclic amines into medium-sized ring amines (tertiary and secondary) by selective cleavage
More informationRN201602_cs5_0122.indd
ISSN 1349-1229 No.416 February 2016 2 SPECIAL TOPIC113 SPECIAL TOPIC 113 FACE Mykinso 113 SPECIAL TOPIC IUPAC 11320151231 RI RIBFRILAC 20039Zn30 Bi83 20047113 20054201283 113 1133 Bh107 20082009 113 113
More informationdrug development Toshimi Michigami, E-mail : michigami@mch.pref.osaka.jp Keiichi Ozono, E-mail : keioz@ped.med.osaka-u.ac.jp The progress in the research on vitamin D 1) McCollum, E. V. et al.:
More informationCM CM VOLVO
CM CM VOLVO - 1 - - 2 - - 3 - - 4 - CM CM CM CM CM CM CM CM CM CM CM - 5 - CM CM CM CM CM CM CM CM CM CM CM CM CM - 6 - 4 CM CM CM CM CM - 7 - CM CM CM CM CM CM CF CF CM CF CM CM CM CM CM CM CM CM CM CM
More information分子標的薬アプデート 2018
Primary imatinib, 2002-2008 (CML IV) 5-year survival 93% n = 2830 Survival probability IFN or SCT, 1997-2008 (CML IIIA) 5-year survival 71% IFN or SCT, 1995-2008 (CML III) 5-year survival 63% IFN, 1986-2003
More informationVENTANA PD-L1 SP142 Rabbit Monoclonal Antibody OptiView PD-L1 SP142
VENTANA PD-L1 SP142 Rabbit Monoclonal Antibody OptiView PD-L1 SP142 2 OptiView PD-L1 SP142 OptiView PD-L1 SP142 OptiView PD-L1 SP142 PD-L1 OptiView PD-L1 SP142 PD-L1 OptiView PD-L1 SP142 PD-L1 OptiView
More information381
P381 P386 P396 P397 P401 P423 P430 P433 P435 P437 P448 P451 P452 381 382 383 384 385 3.0mm 5.0mm 3.0mm 5.0mm SK SK3.0mm SK5.0mm 3.0mm PUR PUR3.0mm 2.0mm 2.0mm3.0mm 2.5mm 2.5mm3.0mm 3.0mm 5.0mm 3.0mm 1.8mm
More informationUniversity of Tsukuba2014
University of Tsukuba S c h o o l o f H e a l t h & P h y s i c a l E d u c a t i o n University of Tsukuba 2014 http://www.taiiku.tsukuba.ac.jp University of Tsukuba2014 School of Health & Physical Education,
More informationH1-H4
42 S H He Li H He Li Be B C N O F Ne Be B C N O F Ne H He Li Be B H H e L i Na Mg Al Si S Cl Ar Na Mg Al Si S Cl Ar C N O F Ne Na Be B C N O F Ne Na K Sc T i V C r K Sc Ti V Cr M n F e C o N i Mn Fe Mg
More informationHOME HEALTH CARE RENTAL CATALOG 90-0408 22 TEL:024-583-5354 FAX:024-583-5359 90-8072 3-9-2 TEL:024-597-8001 FAX:024-597-8002 93-0725 70-1 TEL:024-941-8 FAX:024-944-3048 99-3441 227 TEL:0242-7-111 FAX:0242-7-1130
More information核49index.indd
1 49 ア 29, 32, 297, 297, 404, 411 406 218, 227, 266, 405 270 297 28 235 257 278 234 277 220 64 80, 232, 424 223, 246, 263, 431 228, 230, 257 250 249 269, 276 30, 222, 226, 246, 417 138 73, 75, 219, 261,
More informationVISPO /表1-4
7 2005 1,132 5,249 362 13,666 311,809 1,359 3,723 1,669 538 3,737 17,418 39,036 75,694 5,281 1,169 161,502 7,463 11,408,436 500,000 13,263 192,052 41,391 49,706 136,232 61,102 12,402,182 11,573,898 273,042
More informationMH MH 9.50 8.50 9.40 8.40 9.30 9.20 8.30 9.10 9.00 8.20 8.90 8.80 8.10 8.70 8.60 8.00 8.50 7.90 8.40 8.30 7.80 8.20 8.10 7.70 8.00 7.60 7.90 7.80 7.50 7.70 7.60 7.40 1 7.50 7.40 7.30 2 7.30 7.20 7.20
More informationSurface Chemisty (Fundamentals). III. Masayuki NAKAGAKI Faculty of Pharmaceutical Sciences, Kyoto University (Sakyo-ku, Kyoto)
Surface Chemisty (Fundamentals). III. Masayuki NAKAGAKI Faculty of Pharmaceutical Sciences, Kyoto University (Sakyo-ku, Kyoto) 8 9 1) H.J. Trurnit, in gmonomolecular Layers h, edited by H. Sobotka,
More information_4th2..
01-07 章 _4th2 了 18.8.25 6:46 PM ページ 110 110 2060 1569 2059201510 01-07 章 _4th2 了 18.8.25 6:46 PM ページ 111 111 43 26 548 795 254 1 3,686 443 283 1,668 4,129 915 6,712 2710 2730 2710 65 201729 20166,712 3,3834,081
More informationmg 8 mg X Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD
31 1 15 20 2016 15 3 65 5 mg 8 mg 10 15 201X 7 1 11 15 Cr 9.84 mg/ dl K 1.5 meq/l CK 24,570 U/L Mb 79,530 ng/ml Mb 230,000 ng/ ml AKI 2 IHD IHD 4 IHD AKI HD 2004 48 Acute Kidney Injury AKI 48 Cr 0.3 mg/dl
More informationその科学と技術 No.48( )
45 CI +,,* a-, +0 a-, +0 a-, +., a-, + +, - +, CD CF - CTS CD a-cd b-cd g-cd a- +., 0 1 2 - +33-. CI CI CD CD a- +., CI a- +0, CD Bacillus circulans T--*.*. 13 a-, +0 CI-1 CI-2. CI-3 +* / CI 0 CI-1 CI-+1
More information1000
1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 SL 1000 1000 1000 1000 1000 1000 1000 1000 1000 ( 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000 1000
More information2013 5
12 (SL) (L) (SL) 2013 5 5 29 () 4 ( ) 7 17 20 ( ) 2 14. 4.17 14. 5. 1 14. 5.22 14. 6. 5 14. 4.17 14. 5. 1 14. 5. 8 14. 5.22 14. 4.17 14. 5. 1 14. 5.22 14. 6. 5 4 10 7 7 10 7 31 8 14.4.10 14.7.10 14.7.31
More information衛生関連総合カタログ
INDEX WHITE MAX TP-14 TP-15 TP-15 1 c /s TP-14 28 300 24 XSSM TP-15 30 100 60 TP-16 28 300 24 XSSM HACCP 100.000 1ft 3 0.5100.000 1ft 3 2.5 TP-1 TP-6 200 100 1 c /s 40 100 SML 1 c /s TP-2 200 40 TP-7 100
More informationタイトシリンダ複動 片ロッド形 CMK2 Series チューブ内径 :φ20~φ40 特長 高耐蝕で長寿命 バリエーションが豊富なカシメタイプ 10 本以下 カタログ No.CB-029S 形番表示方法 スイッチなし ( スイッチ用磁石内蔵 ) CMK スイッチ付 ( スイッチ用磁石
タイトシリンダ複動 片ロッド形 CMK2 Series チューブ内径 :φ20~φ40 特長 高耐蝕で長寿命 バリエーションが豊富なカシメタイプ 10 本以下 カタログ No.CB-029S 形番表示方法 スイッチなし ( スイッチ用磁石内蔵 ) CMK2 00 20 スイッチ付 ( スイッチ用磁石内蔵 ) CMK2 00 20 100 T2H R Y A 100 Y B C D E F 標準価格
More information平成27年度三菱重工グループ保険 フルガードくん(シニア)
TEL 0120-004-443 TEL 045-200-6560 TEL 042-761-2328 TEL 0120-539-022 TEL 042-762-0535 TEL 052-565-5211 TEL 077-552-9161 TEL 0120-430-372 TEL 0120-45-9898 TEL 0120-63-0051 TEL 0120-252-892 TEL 083-266-8041
More information技適番号 JARL 日本マランツ株式会社 C4200 KU086 ***** 日本マランツ株式会社 C4200D KU085 ***** 日本マランツ株式会社 C450 S55 日本マランツ株式会社 C460 A052S 日本マランツ株式会社 C470 KV061 ***** 日本マランツ株式会社
技適番号 JARL アルインコ株式会社 ALD-23 AL40 アルインコ株式会社 ALD-23D AL41M アルインコ株式会社 ALD-23DX AL51M アルインコ株式会社 ALD-23SX AL50 アルインコ株式会社 ALD-24 AL36 アルインコ株式会社 ALD-24D AL37M アルインコ株式会社 ALD-24DX AL53M アルインコ株式会社 ALD-24SX AL52 アルインコ株式会社
More information